Open AccessFulminant streptococcal infection with early immunoglobulin introduction resulting in a favourable outcome for both mother and new‐born: A case report
Author(s) -
Sato Takanori,
Oyama Rie,
Baba Tsukasa
Publication year - 2022
Publication title -
reproductive, female and child health
Language(s) - English
Resource type - Journals
ISSN - 2768-7228
DOI - 10.1002/rfc2.14
Subject(s) - medicine , sore throat , cefepime , fulminant , piperacillin , clindamycin , streptococcus agalactiae , toxic shock syndrome , pharyngitis , streptococcus , pediatrics , antibiotics , surgery , imipenem , microbiology and biotechnology , staphylococcus aureus , antibiotic resistance , genetics , bacteria , pseudomonas aeruginosa , biology
The antibacterial agent was changed from cefepime to piperacillin and clindamycin for streptococcal toxic shock syndrome, and an emergency cesarean section was performed. Immunoglobulin was added on the first postoperative day. Group A Streptococcus was isolated on the second postoperative day. Case A 37‐year old woman visited her doctor with complaints of sore throat and fever at 32 weeks gestation, she visited her previous doctor for sore throat and fever. She was treated with cefepime and transported to hospital. Conclusion Antimicrobial therapy and combined immunoglobulin administration were continued. Both mother and infant survived.